| 1 | Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents. (Chen W, Fan H, Balakrishnan K, Wang Y, Sun H, Fan Y, Gandhi V, Arnold LA, Peng X) J Med Chem 2018 Oct 25;61(20):9132-9145 54 Citations |
| 1 | A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphoma. (Maddocks K, Christian B, Jaglowski S, Flynn J, Jones JA, Porcu P, Wei L, Jenkins C, Lozanski G, Byrd JC, Blum KA) Blood 2015 Jan 08;125(2):242-8 126 Citations |
| 1 | Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancer. (Tsimberidou AM, Adamopoulos AM, Ye Y, Piha-Paul S, Janku F, Fu S, Hong D, Falchook GS, Naing A, Wheler J, Fortier A, Kurzrock R, Hess KR) J Natl Compr Canc Netw 2014 Feb;12(2):194-203 3 Citations |
| 1 | Open-label bendamustine monotherapy for pediatric patients with relapsed or refractory acute leukemia: efficacy and tolerability. (Fraser C, Brown P, Megason G, Ahn HS, Cho B, Kirov I, Frankel L, Aplenc R, Bensen-Kennedy D, Munteanu M, Weaver J, Harker-Murray P) J Pediatr Hematol Oncol 2014 May;36(4):e212-8 11 Citations |
| 1 | Unilateral pulmonary edema. An unusual complication of nitrogen mustard therapy. (Goodman LR, Shanser JD) Radiology 1976 Jul;120(1):166 3 Citations |
